Work

TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial

Year: 2006

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: The Lancet Neurology

DOI: 10.1016/s1474-4422(06)70602-0

Authors: C Warren Olanow, Anthony HV Schapira, Peter A LeWitt, Karl Kieburtz, Dirk Sauer, Gianfranco Olivieri, Harald Pohlmann, Jean Hubble

Institutions: Icahn School of Medicine at Mount Sinai, The Royal Free Hospital, UCL Queen Square Institute of Neurology, University College London, Wayne State University, University of Rochester Medicine, University of Rochester, Novartis (Switzerland)

Language: English

Topic: Parkinson's Disease Mechanisms and Treatments

Subfield: Clinical Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2068915923

FWCI: 11.06

Cites: 61

Cited by: 178

Related to: 10